Reata Pharmaceuticals Inc... (RETA)
NASDAQ: RETA
· Real-Time Price · USD
172.36
0.04 (0.02%)
At close: Sep 25, 2023, 10:00 PM
Reata Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| License and Service Revenue | 1.65M |
| License and Service Revenue Growth | n/a |
| Service, Other Revenue | 568K |
| Service, Other Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 45.69M | 54.88M | 32.02M | 27.27M | 25.14M | 24.84M | 30.56M | 25.74M | 22M | 20.7M | 19.43M | 18.31M | 16.6M | 20.79M | 22.27M | 14.28M | 11.71M | 10.04M | 7.95M | 7.49M | 10.69M | 6.63M | 5.95M | 6.15M | 5.99M | 5.17M | 4.82M | 4.04M | 4.54M | 3.21M | 4.49M | 2.98M | 3.37M | 2.85M |
| Selling, General, and Administrative Revenue Growth | -16.75% | +71.39% | +17.43% | +8.46% | +1.22% | -18.72% | +18.75% | +16.99% | +6.25% | +6.57% | +6.08% | +10.33% | -20.14% | -6.66% | +55.93% | +22.01% | +16.62% | +26.34% | +6.13% | -29.97% | +61.27% | +11.43% | -3.30% | +2.69% | +15.79% | +7.32% | +19.34% | -10.98% | +41.47% | -28.57% | +50.67% | -11.55% | +18.04% | n/a |
| Research and Development Revenue | 57.12M | 55.48M | 47.22M | 43.48M | 39.33M | 39.8M | 41.62M | 39.43M | 40.07M | 34.88M | 37.46M | 37.18M | 36.78M | 47.65M | 40.16M | 32.28M | 29.55M | 26.11M | 25.31M | 27.14M | 23.43M | 21.41M | 20.44M | 18.33M | 17.9M | 14.6M | 11.77M | 9.3M | 9.07M | 9.31M | 8.32M | 8.55M | 9.69M | 8.58M |
| Research and Development Revenue Growth | +2.96% | +17.48% | +8.60% | +10.56% | -1.19% | -4.35% | +5.54% | -1.59% | +14.87% | -6.89% | +0.75% | +1.09% | -22.81% | +18.65% | +24.42% | +9.22% | +13.17% | +3.18% | -6.76% | +15.86% | +9.45% | +4.72% | +11.55% | +2.37% | +22.58% | +24.05% | +26.58% | +2.48% | -2.48% | +11.78% | -2.63% | -11.75% | +12.94% | n/a |